Growth hormone response to apomorphine in obsessive-compulsive disorder

Journal of Psychiatry and Neuroscience

Volumn 21, Issue 5, 1996, Pages 343-345

  Pitchot, William ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

comorbidity; dopamine; obsessive compulsive disorder

Indexed keywords

APOMORPHINE; DOPAMINE; GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; MORBIDITY; OBSESSION; PATHOPHYSIOLOGY;

ADULT; APOMORPHINE; DOPAMINE AGONISTS; FEMALE; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER;

EID: 0030461977     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. American Psychiatric Association. 1987. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised. Washington (DC): American Psychiatric Association.
2. Ansseau M, von Frenckell R, Cerfontaine JL, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros JJ. 1988. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiatry 153:65-71.